PhRMA Code Revisions: Benchmarking of Leading Pharmaceutical Companies' Approaches and Responses
 
New Page 1 This report examines how leading pharmaceutical and biotech companies are interpreting the new PhRMA guidelines. The study examines the policies of 10 leading companies and provides specific tactics and policies implemented in response to the newly revised PhRMA Code.

The study provides a clear understanding of each company's interpretation of and response to the code in regards to the following:

  • Defintion of a health care professional (HCP)
  • Classification of employees who are subject to the PhRMA Code
  • Restrictions on interactions between field sales and HCPs
  • Definition of 'modest meals' provided to HCPs
  • Restrictions on educational and non-educational items
  • Description of speaker training programs
  • Current grant process
  • Key attributes of advisory boards
  • PhRMA Code training

To receive more information about the study, including a list of companies analyzed and sample pages, click on the Contact Us link.